Leander JD - Search Results

1

GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Burgdorf J, Zhang XL, Nicholson KL, Balster RL, Leander JD, Stanton PK, Gross AL, Kroes RA, Moskal JR. Burgdorf J, et al. Among authors: leander jd. Neuropsychopharmacology. 2013 Apr;38(5):729-42. doi: 10.1038/npp.2012.246. Epub 2012 Dec 5. Neuropsychopharmacology. 2013. PMID: 23303054 Free PMC article.

2

GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists.

Moskal JR, Burch R, Burgdorf JS, Kroes RA, Stanton PK, Disterhoft JF, Leander JD. Moskal JR, et al. Among authors: leander jd. Expert Opin Investig Drugs. 2014 Feb;23(2):243-54. doi: 10.1517/13543784.2014.852536. Epub 2013 Nov 20. Expert Opin Investig Drugs. 2014. PMID: 24251380 Free PMC article. Review.

3

The behavioral pharmacology of NMDA receptor antagonists.

Willetts J, Balster RL, Leander JD. Willetts J, et al. Among authors: leander jd. Trends Pharmacol Sci. 1990 Oct;11(10):423-8. doi: 10.1016/0165-6147(90)90150-7. Trends Pharmacol Sci. 1990. PMID: 2147794 Review.

4

Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon.

Wolff MC, Leander JD. Wolff MC, et al. Among authors: leander jd. Neuropsychopharmacology. 2002 Sep;27(3):421-9. doi: 10.1016/S0893-133X(02)00307-X. Neuropsychopharmacology. 2002. PMID: 12225699

5

Synthesis and pharmacology of a series of 3- and 4-(phosphonoalkyl)pyridine- and -piperidine-2-carboxylic acids. Potent N-methyl-D-aspartate receptor antagonists.

Ornstein PL, Schaus JM, Chambers JW, Huser DL, Leander JD, Wong DT, Paschal JW, Jones ND, Deeter JB. Ornstein PL, et al. Among authors: leander jd. J Med Chem. 1989 Apr;32(4):827-33. doi: 10.1021/jm00124a015. J Med Chem. 1989. PMID: 2539478

6

Behavioral pharmacology of olanzapine: a novel antipsychotic drug.

Moore NA, Leander JD, Benvenga MJ, Gleason SD, Shannon H. Moore NA, et al. Among authors: leander jd. J Clin Psychiatry. 1997;58 Suppl 10:37-44. J Clin Psychiatry. 1997. PMID: 9265915 Review.

7

NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.

Moore NA, Blackman A, Awere S, Leander JD. Moore NA, et al. Among authors: leander jd. Eur J Pharmacol. 1993 Jun 11;237(1):1-7. doi: 10.1016/0014-2999(93)90085-v. Eur J Pharmacol. 1993. PMID: 8359205

8

Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists.

Ornstein PL, Arnold MB, Lunn WH, Heinz LJ, Leander JD, Lodge D, Schoepp DD. Ornstein PL, et al. Among authors: leander jd. Bioorg Med Chem Lett. 1998 Feb 17;8(4):389-94. doi: 10.1016/s0960-894x(98)00038-9. Bioorg Med Chem Lett. 1998. PMID: 9871691

9

D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist.

Schoepp DD, Smith CL, Lodge D, Millar JD, Leander JD, Sacaan AI, Lunn WH. Schoepp DD, et al. Among authors: leander jd. Eur J Pharmacol. 1991 Oct 15;203(2):237-43. doi: 10.1016/0014-2999(91)90719-7. Eur J Pharmacol. 1991. PMID: 1686860

10

Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist.

Schoepp DD, Ornstein PL, Salhoff CR, Leander JD. Schoepp DD, et al. Among authors: leander jd. J Neural Transm Gen Sect. 1991;85(2):131-43. doi: 10.1007/BF01244705. J Neural Transm Gen Sect. 1991. PMID: 1834088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters